Company news
S.m.a.i.o S.a. (EURONEXT:ALSMA) news
S.m.a.i.o S.a. news releases on 6ix. Latest, Sep 3, 2026: SMAIO has Reappointed Dr Donald J. Blaskiewicz to its Scientific Advisory Board in the United States
Press releases & updates
SMAIO has Reappointed Dr Donald J. Blaskiewicz to its Scientific Advisory Board in the United States
September 3, 2026
SMAIO Reports Sales for the First Half of 2026
July 16, 2026
SMAIO : Quarterly financial reporting / First quarter financial report
May 12, 2026
SMAIO Reported Revenue of €2.8 Million in the First Quarter of 2026, an Increase of 11%
May 12, 2026
SMAIO Expands Its North American Scientific Advisory Board With a New Renowned Surgeon
May 11, 2026
SMAIO Announces that Portzamparc (BNP Paribas Group) has Initiated Coverage of its Stock with a Buy Rating
May 5, 2026
SMAIO Reports Strong FY 2025 Results, Amid Robust Growth in Activity
April 14, 2026
SMAIO Announces a €3.6 Million Capital Increase to Support Its Long-Term Growth Momentum
March 6, 2026
SMAIO : INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL
March 4, 2026
SMAIO Reports 2025 Sales of €9.2m, Representing an Increase of +67%
January 20, 2026
SMAIO: 2026 Financial Calendar
January 8, 2026
SMAIO Obtains €2.0m in Non-Dilutive Financing
January 6, 2026
SMAIO Successfully Continues Its Think Tanks Focused on Promoting Its Innovative Solutions in the United States
December 19, 2025
SMAIO Appoints Matthieu Ville as Chief Commercial Officer to Accelerate Commercialization and Strengthen Its Leadership in Spinal Realignment
November 24, 2025
SMAIO Adds a New High-Profile Member to Its Scientific Advisory Board in the United States
November 3, 2025
SMAIO Signs a New Distribution Agreement for Its Open Platform KEOPS-4ME With Orthofix in the U.S.
October 22, 2025
SMAIO Announces Strong First-Half 2025 Results and Robust Growth in Business Activity in the Third Quarter of 2025
October 14, 2025
SMAIO Signs the First Major Distribution Agreement for Its Open Platform KEOPS-4ME with Highridge Medical in the U.S.
September 24, 2025
SMAIO Announces Significant Sales Increase in H1 2025
July 16, 2025
SMAIO Announces the Finalization of a €2.5 Million Fund-Raising, Consisting of a €1.5 Million Capital Increase and a €1 Million Convertible Bond Issue
May 12, 2025
SMAIO Announces Consolidated Results for 2024 and Record Sales Performance in Q1 2025
April 15, 2025